Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...
The fund returned 25.75% in Q3 2025, significantly outperforming its benchmark through strategic positioning in AI ...
Guided by the Xi Jinping Thought on the Rule of Law, China has been advancing the development of a law-based governance ...
Oramed (ORMP) targets a new patient subset after FDA setback. Learn how promising trials may revive its protein oral delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback